Search

everythinglearnresearchcommunity

for

Search:↓

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Blocking LFA-1 prevents hair loss in mice.

Adalimumab may cause severe hair loss in some patients.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Jawarish Falafali improved hypothyroidism symptoms and reduced TSH levels.

Upadacitinib improved multiple immune-related conditions in one patient.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.